Recent Quotes (30 days)

You have no recent quotes
chg | %

biOasis Technologies Inc  

(Public, CVE:BTI)   Watch this stock  
Find more results for BTI
1.02
+0.02 (2.00%)
Aug 28 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.00 - 1.03
52 week 0.75 - 1.50
Open 1.03
Vol / Avg. 12,000.00/28,185.00
Mkt cap 45.01M
P/E     -
Div/yield     -
EPS -0.07
Shares 44.13M
Beta 0.41
Inst. own     -

Key stats and ratios

Q2 (May '15) 2015
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -169.03% -118.42%
Return on average equity -184.30% -129.04%
CDP Score - -

Address

Suite 125, 10551 Shellbridge Way
RICHMOND, BC V6X 2W9
Canada
+1-778-3833280 (Phone)
+1-604-2150091 (Fax)

Website links

Description

biOasis Technologies Inc. is an early-stage biopharmaceutical company. The Company is focused on research, development and commercialization of technologies and products intended for the treatment of central nervous system (CNS) diseases and diseases of the brain. It is engaged in the development of vectors, such as Transcend and Transcendpep for the transport of therapeutic agents across the blood brain barrier (BBB). Its programs include Transcend Program, Oncology Program, Peptide Program, Transcendpep-siRNA Program and Collaborations and Internal Research and Development Program. The Transcend brain delivery platform exploits the BBB penetrating properties of a recombinant soluble human protein known as melanotransferrin. It has initiated Transcend Vector Program for treatment of CNS symptoms of lysosomal storage diseases and studies to assess the therapeutic potential of the delivery of Herceptin to the brain for the treatment of brain metastases of HER2-positive breast cancer.

Officers and directors

Robin B. Hutchison Chairman of the Board, President, Chief Executive Officer
Age: 58
Judi Dalling Chief Financial Officer, Corporate Secretary
Ronald P Erickson Independent Director
Age: 71
H. Christian Fibiger P.hD. Independent Director
Age: 71
Greg D. Gubitz Independent Director
Age: 57
J. Michael Hutchison QC Independent Director
Age: 70
Terry Pearson Ph.D. Independent Director
Age: 68